In male Kunming mice, intragastric Meldonium pretreatment reduced mortality under hypoxia in a dose-dependent manner compared with hypoxia-treated saline controls. In male Sprague–Dawley MCAO rats, intravenous Meldonium significantly decreased neurological deficit scores after reperfusion compared with MCAO rats. In KPPC mice, oral Meldonium prolonged survival compared with vehicle treatment. [2,1,3]
Mortality under hypoxia in mice
Animal study · male Kunming mice; n = 8 [2]
Male Kunming mice received intragastric Meldonium pretreatment before hypoxia induction. Pretreatment reduced mortality in a dose-dependent manner compared with the hypoxia-treated saline group.
Conditions shared by the study groups
- Route
- intragastrically
- Treatment course
- daily for 3 days prior to the induction of hypoxia
- Vehicle
- 0.9% saline
- Meldonium 50 mg/kg, 100 mg/kg, 200 mg/kg
- Model: male Kunming mice; n = 8
Methods and source locations
Compound reported in the paper: Meldonium
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Chemicals, reagents, and antibodies (S1); Methods > Induction of acute hypobaric hypoxia brain injury and treatment (S14, S15, S16, S17); Results > Pretreatment with meldonium rescued acute hypobaric hypoxia-induced pathological injury of brain (S91, S99)
Mortality rate under hypoxia exposure: Mortality rate under hypoxia exposure; comparator: the hypoxia-treated 0.9% saline group — Results > Pretreatment with meldonium rescued acute hypobaric hypoxia-induced pathological injury of brain (S91, S99)
Meldonium 50 mg/kg, 100 mg/kg, 200 mg/kg · Methods > Induction of acute hypobaric hypoxia brain injury and treatment (S14, S15); Results > Pretreatment with meldonium rescued acute hypobaric hypoxia-induced pathological injury of brain (S91)
Neurological deficits in MCAO rats
Animal study · Male Sprague–Dawley rats; MCAO rats [1]
In male Sprague–Dawley MCAO rats, intravenous Meldonium treatment significantly decreased neurological deficit scores after reperfusion compared with MCAO rats.
Conditions shared by the study groups
- Route
- intravenously
- Treatment course
- 1 h after ischemia and 5 h after reperfusion
- Vehicle
- saline
- Meldonium 100 mg/kg, 200 mg/kg
- Model: Male Sprague–Dawley rats; MCAO rats
Methods and source locations
Compound reported in the paper: Meldonium
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Animals and treatment (S1, S3, S6); Materials and methods > Establishment of MCAO-induced rat cerebral ischemic injury models (S7); Results > Meldonium improves motor function and alleviates apoptosis in the cerebral cortex and hippocampus of MCAO rats (S102); Fig. 1 legend (S181)
neurological deficit score after reperfusion for 24 h: neurological deficit score after reperfusion for 24 h; comparator: saline-treated MCAO rats (vehicle; n = 8) — Results > Meldonium improves motor function and alleviates apoptosis in the cerebral cortex and hippocampus of MCAO rats (S102); Fig. 1 legend (S181)
Meldonium 100 mg/kg, 200 mg/kg · Materials and methods > Animals and treatment (S6); Results > Meldonium improves motor function and alleviates apoptosis in the cerebral cortex and hippocampus of MCAO rats (S102)
Survival in KPPC mice
Animal study · LSL-KrasG12D/+;Trp53flox/flox;Pdx-1cre/+ (KPPC) mice; C57BL/6 background [3]
KPPC mice received oral Meldonium and were followed until the humane endpoint. Meldonium-treated mice showed prolonged survival compared with vehicle-treated KPPC mice by Kaplan–Meier analysis.
Conditions shared by the study groups
- Route
- orally administered
- Treatment course
- Six-week-old KPPC mice; followed up until the humane endpoint
- Vehicle
- distilled water
- Meldonium 100 mg/kg/day
- Model: LSL-KrasG12D/+;Trp53flox/flox;Pdx-1cre/+ (KPPC) mice; C57BL/6 background
Methods and source locations
Compound reported in the paper: Meldonium
Evidence for Meldonium as the dihydrate form reported in the paper, not the free base/neutral form supplied as A12316; no salt equivalence, dose conversion or lot validation.
Results > Blocking BBOX1 inhibited PDAC and prolonged survival in mice with PDAC (S24); STAR★Methods > Experimental model and study participant details > Mouse models and animal study approval (S82, S83); STAR★Methods > Method details > Meldonium administration in vivo (S142, S143)
survival rate: survival rate; comparator: vehicle-treated KPPC mice (n = 14) — Results > Blocking BBOX1 inhibited PDAC and prolonged survival in mice with PDAC (S24)
Meldonium 100 mg/kg/day · Results > Blocking BBOX1 inhibited PDAC and prolonged survival in mice with PDAC (S24); STAR★Methods > Method details > Meldonium administration in vivo (S143)